Investment Stage

Focus Areas

About Investor

Jonathan Behr is Partner at SV Health Investors on the therapeutics team. He co-leads the Dementia Discovery Fund and serves as a director or observer for portfolio companies including Montara Therapeutics, Nitrase Therapeutics, QurAlis, Ribometrix, Sudo Therapeutics, Transposon Therapeutics, and Violet Therapeutics. Signal lists his investment range as $100K - $5.0M with a $1.5M sweet spot. Before SV, he was the first Managing Director of the T1D Fund, held senior venture-creation roles at PureTech Ventures and Enlight Biosciences, and worked at Partners Healthcare Innovation.